Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2D325F277N
- Awardee
-
Chartwell RX LLC UEI ER5UA9TYBGH4
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,185
Award facts
- Contract value 100% obligated
- $1,184.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Congers, NY 10920, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,184.50 to Chartwell RX LLC for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. The award was issued on July 30, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. Chartwell RX LLC, a pharmaceutical company headquartered in Congers, New York, will fulfill this order from its place of performance at the same location. The company has been registered in the System for Award Management since April 2019 and maintains established relationships with federal healthcare agencies through multiple indefinite delivery vehicle contracts.
This delivery order represents a continuation of Chartwell RX's ongoing role in supporting federal pharmaceutical supply requirements. Ondansetron is a critical antiemetic medication widely used in military treatment facilities and government healthcare systems. The firm fixed-price structure and compressed timeline reflect the urgent nature of pharmaceutical procurement within the defense logistics network. Chartwell RX's extensive portfolio of federal contracts, including substantial awards for generic oral medications such as doxycycline and other therapeutic agents, demonstrates the company's established capabilities and reliability as a prime contractor within the Defense Logistics Agency's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2D325F277N?
SPE2D325F277N was awarded to Chartwell RX LLC by Medical Supply Chain (Troop Support) on July 30, 2025.
How much is contract SPE2D325F277N worth?
The government has obligated $1,185 on SPE2D325F277N.
Is contract SPE2D325F277N an order under another contract?
Yes. SPE2D325F277N is a delivery order under SPE2D020D0005, an indefinite delivery contract.
Was contract SPE2D325F277N competed?
The extent of competition for SPE2D325F277N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award